CD73 expression in tumor cells was most strongly associated with inflammatory signaling pathways, including chemokine secretion (CXCL2), major histocompatibility complex class I (MHC-I) expression, and interferon signaling (Fig. S1f). The gene discussed is CXCL2; the disease is neoplasm.